Kopiryna – Tabletki Od Bólu Głowy (Acetylsalicylic Acid, Caffeine)

Acetylsalicylic acid irreversibly inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which reduces the synthesis of prostaglandins—compounds that mediate pain, inflammation and fever. By lowering prostaglandin levels, the drug produces analgesic, antipyretic and anti‑inflammatory effects.

The appropriate dose of Kopiryna is determined by a qualified prescriber based on the individual’s age, medical condition and response to therapy. Patients should follow the healthcare professional’s instructions and never exceed the recommended amount on the product label.

Safety of Kopiryna in pregnancy or while nursing has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using this medication to weigh potential risks and benefits.

To order Kopiryna, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Kopiryna combines aspirin with caffeine, offering both anti‑platelet activity and enhanced analgesia compared with plain aspirin. Compared with ibuprofen, it may have a slightly higher risk of gastrointestinal irritation but provides a quicker onset due to caffeine. Unlike paracetamol, it has anti‑inflammatory properties but is not suitable for patients with aspirin allergy.

Store Kopiryna tablets at room temperature, preferably below 25 °C. Keep the container tightly closed, protect it from moisture, heat and direct sunlight, and store it out of reach of children.

Kopiryna is taken orally with a full glass of water. The tablet should be swallowed whole and not chewed or crushed. It can be taken with or without food, although taking it with food may reduce stomach irritation.

The most serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and rare but serious skin conditions like Stevens‑Johnson syndrome. Patients experiencing unusual bruising, persistent stomach pain, or signs of an allergic reaction should seek medical attention promptly.

Kopiryna should be avoided by individuals with known hypersensitivity to aspirin, other NSAIDs, or caffeine; those with active peptic ulcer disease, uncontrolled bleeding disorders, severe liver or kidney impairment; and children under 12 years of age. Pregnant women and breastfeeding mothers should consult a healthcare professional before use.